BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31877728)

  • 1. RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats.
    Huynh PN; Giuvelis D; Christensen S; Tucker KL; McIntosh JM
    Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31877728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.
    Romero HK; Christensen SB; Di Cesare Mannelli L; Gajewiak J; Ramachandra R; Elmslie KS; Vetter DE; Ghelardini C; Iadonato SP; Mercado JL; Olivera BM; McIntosh JM
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1825-E1832. PubMed ID: 28223528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3
    Huynh PN; Christensen SB; McIntosh JM
    Cells; 2022 Nov; 11(22):. PubMed ID: 36428990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain.
    Wang H; Li X; Zhangsun D; Yu G; Su R; Luo S
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31060282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
    Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
    Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Crystal Structures of RgIA4 in Complex with
    Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X
    Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia.
    Christensen SB; Hone AJ; Roux I; Kniazeff J; Pin JP; Upert G; Servent D; Glowatzki E; McIntosh JM
    Front Cell Neurosci; 2017; 11():219. PubMed ID: 28785206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain.
    Zheng N; Christensen SB; Dowell C; Purushottam L; Skalicky JJ; McIntosh JM; Chou DH
    J Med Chem; 2021 Jul; 64(13):9513-9524. PubMed ID: 34161094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2].
    Li Z; Han X; Hong X; Li X; Gao J; Zhang H; Zheng A
    Mar Drugs; 2021 Feb; 19(3):. PubMed ID: 33668830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.
    Wala EP; Crooks PA; McIntosh JM; Holtman JR
    Anesth Analg; 2012 Sep; 115(3):713-20. PubMed ID: 22610850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.
    Mori T; Kanbara T; Harumiya M; Iwase Y; Masumoto A; Komiya S; Nakamura A; Shibasaki M; Kanemasa T; Sakaguchi G; Suzuki T
    J Pharmacol Sci; 2014; 126(1):47-55. PubMed ID: 25141998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
    Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. αO-Conotoxin GeXIVA[1,2] Reduced Neuropathic Pain and Changed Gene Expression in Chronic Oxaliplatin-Induced Neuropathy Mice Model.
    Wang H; Li X; Qiao Y; Wang M; Wang W; McIntosh JM; Zhangsun D; Luo S
    Mar Drugs; 2024 Jan; 22(1):. PubMed ID: 38276651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.
    Xiao WH; Bennett GJ
    Pain; 2012 Mar; 153(3):704-709. PubMed ID: 22244441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic Acetylcholine Receptors Mediate the Suppressive Effect of an Injection of Diluted Bee Venom into the GV3 Acupoint on Oxaliplatin-Induced Neuropathic Cold Allodynia in Rats.
    Yoon H; Kim MJ; Yoon I; Li DX; Bae H; Kim SK
    Biol Pharm Bull; 2015; 38(5):710-4. PubMed ID: 25752933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.
    Gajewiak J; Christensen SB; Dowell C; Hararah F; Fisher F; Huynh PN; Olivera BM; McIntosh JM
    J Med Chem; 2021 Jul; 64(13):9271-9278. PubMed ID: 34142837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy.
    Flatters SJ; Bennett GJ
    Pain; 2004 May; 109(1-2):150-61. PubMed ID: 15082137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement.
    Di Cesare Mannelli L; Cinci L; Micheli L; Zanardelli M; Pacini A; McIntosh JM; Ghelardini C
    Pain; 2014 Oct; 155(10):1986-95. PubMed ID: 25008370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hypersensitive effect of intramuscular administration of αO-conotoxin GeXIVA[1,2] and GeXIVA[1,4] in rats of neuropathic pain.
    Li X; Hu Y; Wu Y; Huang Y; Yu S; Ding Q; Zhangsun D; Luo S
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Apr; 66():112-119. PubMed ID: 26706456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms.
    Vitet L; Patte-Mensah C; Boujedaini N; Mensah-Nyagan AG; Meyer L
    Neurol Sci; 2018 Dec; 39(12):2183-2196. PubMed ID: 30251080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.